Medical devices as a sub-sector of the biotech industry have been performing well in recent months a...
Medical devices as a sub-sector of the biotech industry have been performing well in recent months as investors look for alternative areas to drug companies. Over the 12 months to 13 July, the S&P drugs index fell 11.51% in dollar terms, the S&P 500 fell 16.88%, whereas the S&P medical products index had dropped by 6.64%. Since May, the S&P medical products index posted a slight gain at 0.64% but this compares to the continued fall on the S&P drugs index of 11.49%. Antony Milford, fund manager of Framlington Health, says that he has done better in the device sector than any other part o...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes